The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Contraceptive Drugs-Global Market Insights and Sales Trends 2024
Synopsis
Contraceptive Drugs are medications that prevent pregnancy. They are one method of birth control
The global Contraceptive Drugs market size is expected to reach US$ 13880 million by 2029, growing at a CAGR of 3.9% from 2023 to 2029. The market is mainly driven by the significant applications of Contraceptive Drugs in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Contraceptive Drugs market. Oral, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Injectable segment is estimated at % CAGR for the next seven-year period.
Birth controls are been used since ancient times but the safe and effective methods are introduce and available from 20th century. Contraceptive drugs are used to prevent the unwanted pregnancy by blocking the normal process of ovulations or by altering the process which support the fertilization of egg.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Contraceptive Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Contraceptive Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Contraceptive Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Contraceptive Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Contraceptive Drugs covered in this report include Merck, Pfizer, Teva Pharmaceutical, Bayer, Allergan, Janssen, Mankind Pharma, Piramal Enterprises and Reckitt Benckiser, etc.
The global Contraceptive Drugs market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck
Pfizer
Teva Pharmaceutical
Bayer
Allergan
Janssen
Mankind Pharma
Piramal Enterprises
Reckitt Benckiser
Church & Dwight
Global Contraceptive Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Contraceptive Drugs market, Segment by Type:
Oral
Injectable
Others
Global Contraceptive Drugs market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Contraceptive Drugs companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Contraceptive Drugs are medications that prevent pregnancy. They are one method of birth control
The global Contraceptive Drugs market size is expected to reach US$ 13880 million by 2029, growing at a CAGR of 3.9% from 2023 to 2029. The market is mainly driven by the significant applications of Contraceptive Drugs in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Contraceptive Drugs market. Oral, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Injectable segment is estimated at % CAGR for the next seven-year period.
Birth controls are been used since ancient times but the safe and effective methods are introduce and available from 20th century. Contraceptive drugs are used to prevent the unwanted pregnancy by blocking the normal process of ovulations or by altering the process which support the fertilization of egg.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Contraceptive Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Contraceptive Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Contraceptive Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Contraceptive Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Contraceptive Drugs covered in this report include Merck, Pfizer, Teva Pharmaceutical, Bayer, Allergan, Janssen, Mankind Pharma, Piramal Enterprises and Reckitt Benckiser, etc.
The global Contraceptive Drugs market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck
Pfizer
Teva Pharmaceutical
Bayer
Allergan
Janssen
Mankind Pharma
Piramal Enterprises
Reckitt Benckiser
Church & Dwight
Global Contraceptive Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Contraceptive Drugs market, Segment by Type:
Oral
Injectable
Others
Global Contraceptive Drugs market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Contraceptive Drugs companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Contraceptive Drugs
1.1 Contraceptive Drugs Market Overview
1.1.1 Contraceptive Drugs Product Scope
1.1.2 Contraceptive Drugs Market Status and Outlook
1.2 Global Contraceptive Drugs Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Contraceptive Drugs Market Size by Region (2018-2029)
1.4 Global Contraceptive Drugs Historic Market Size by Region (2018-2023)
1.5 Global Contraceptive Drugs Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Contraceptive Drugs Market Size (2018-2029)
1.6.1 North America Contraceptive Drugs Market Size (2018-2029)
1.6.2 Europe Contraceptive Drugs Market Size (2018-2029)
1.6.3 Asia-Pacific Contraceptive Drugs Market Size (2018-2029)
1.6.4 Latin America Contraceptive Drugs Market Size (2018-2029)
1.6.5 Middle East & Africa Contraceptive Drugs Market Size (2018-2029)
2 Contraceptive Drugs Market by Type
2.1 Introduction
2.1.1 Oral
2.1.2 Injectable
2.1.3 Others
2.2 Global Contraceptive Drugs Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Contraceptive Drugs Historic Market Size by Type (2018-2023)
2.2.2 Global Contraceptive Drugs Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Contraceptive Drugs Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Contraceptive Drugs Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Contraceptive Drugs Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Contraceptive Drugs Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Contraceptive Drugs Revenue Breakdown by Type (2018-2029)
3 Contraceptive Drugs Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
3.2 Global Contraceptive Drugs Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Contraceptive Drugs Historic Market Size by Application (2018-2023)
3.2.2 Global Contraceptive Drugs Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Contraceptive Drugs Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Contraceptive Drugs Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Contraceptive Drugs Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Contraceptive Drugs Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Contraceptive Drugs Revenue Breakdown by Application (2018-2029)
4 Contraceptive Drugs Competition Analysis by Players
4.1 Global Contraceptive Drugs Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Contraceptive Drugs as of 2022)
4.3 Date of Key Players Enter into Contraceptive Drugs Market
4.4 Global Top Players Contraceptive Drugs Headquarters and Area Served
4.5 Key Players Contraceptive Drugs Product Solution and Service
4.6 Competitive Status
4.6.1 Contraceptive Drugs Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Merck
5.1.1 Merck Profile
5.1.2 Merck Main Business
5.1.3 Merck Contraceptive Drugs Products, Services and Solutions
5.1.4 Merck Contraceptive Drugs Revenue (US$ Million) & (2018-2023)
5.1.5 Merck Recent Developments
5.2 Pfizer
5.2.1 Pfizer Profile
5.2.2 Pfizer Main Business
5.2.3 Pfizer Contraceptive Drugs Products, Services and Solutions
5.2.4 Pfizer Contraceptive Drugs Revenue (US$ Million) & (2018-2023)
5.2.5 Pfizer Recent Developments
5.3 Teva Pharmaceutical
5.3.1 Teva Pharmaceutical Profile
5.3.2 Teva Pharmaceutical Main Business
5.3.3 Teva Pharmaceutical Contraceptive Drugs Products, Services and Solutions
5.3.4 Teva Pharmaceutical Contraceptive Drugs Revenue (US$ Million) & (2018-2023)
5.3.5 Bayer Recent Developments
5.4 Bayer
5.4.1 Bayer Profile
5.4.2 Bayer Main Business
5.4.3 Bayer Contraceptive Drugs Products, Services and Solutions
5.4.4 Bayer Contraceptive Drugs Revenue (US$ Million) & (2018-2023)
5.4.5 Bayer Recent Developments
5.5 Allergan
5.5.1 Allergan Profile
5.5.2 Allergan Main Business
5.5.3 Allergan Contraceptive Drugs Products, Services and Solutions
5.5.4 Allergan Contraceptive Drugs Revenue (US$ Million) & (2018-2023)
5.5.5 Allergan Recent Developments
5.6 Janssen
5.6.1 Janssen Profile
5.6.2 Janssen Main Business
5.6.3 Janssen Contraceptive Drugs Products, Services and Solutions
5.6.4 Janssen Contraceptive Drugs Revenue (US$ Million) & (2018-2023)
5.6.5 Janssen Recent Developments
5.7 Mankind Pharma
5.7.1 Mankind Pharma Profile
5.7.2 Mankind Pharma Main Business
5.7.3 Mankind Pharma Contraceptive Drugs Products, Services and Solutions
5.7.4 Mankind Pharma Contraceptive Drugs Revenue (US$ Million) & (2018-2023)
5.7.5 Mankind Pharma Recent Developments
5.8 Piramal Enterprises
5.8.1 Piramal Enterprises Profile
5.8.2 Piramal Enterprises Main Business
5.8.3 Piramal Enterprises Contraceptive Drugs Products, Services and Solutions
5.8.4 Piramal Enterprises Contraceptive Drugs Revenue (US$ Million) & (2018-2023)
5.8.5 Piramal Enterprises Recent Developments
5.9 Reckitt Benckiser
5.9.1 Reckitt Benckiser Profile
5.9.2 Reckitt Benckiser Main Business
5.9.3 Reckitt Benckiser Contraceptive Drugs Products, Services and Solutions
5.9.4 Reckitt Benckiser Contraceptive Drugs Revenue (US$ Million) & (2018-2023)
5.9.5 Reckitt Benckiser Recent Developments
5.10 Church & Dwight
5.10.1 Church & Dwight Profile
5.10.2 Church & Dwight Main Business
5.10.3 Church & Dwight Contraceptive Drugs Products, Services and Solutions
5.10.4 Church & Dwight Contraceptive Drugs Revenue (US$ Million) & (2018-2023)
5.10.5 Church & Dwight Recent Developments
6 North America
6.1 North America Contraceptive Drugs Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Contraceptive Drugs Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Contraceptive Drugs Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Contraceptive Drugs Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Contraceptive Drugs Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Contraceptive Drugs Market Dynamics
11.1 Contraceptive Drugs Industry Trends
11.2 Contraceptive Drugs Market Drivers
11.3 Contraceptive Drugs Market Challenges
11.4 Contraceptive Drugs Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
